On September 8, 2021 Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized, and targeted induced pluripotent stem cells (iPSC) derived natural killer (NK) and Macrophage cellular immunotherapies, reported that company management will present and be available for one-on-one meetings at the Wells Fargo 2021 Virtual Healthcare Conference, September 9 -10, 2021, and the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021 (Press release, Shoreline Biosciences, SEP 8, 2021, View Source [SID1234587445]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details on the presentations can be found below.

Wells Fargo 2021 Virtual Healthcare Conference
September 9, 2021 at 12:40 PM ET

H.C. Wainwright 23rd Annual Global Investment Conference
Presentation Date: Corporate presentation will be available on-demand to conference
registrants starting at 7:00 AM ET on September 13, 2021